By Jeremy A. Horst, DDS, PhD; Hellene Ellenikiotis, DDS; and Peter L. Milgrom, DDS
From the California Dental Assoication, With Permission to Reprint
In the Spring 2018 Journal of the Colorado Dental Association
Abstract
The Food and Drug Administration recently cleared silver diamine fluoride for reducing tooth sensitivity. Clinical trials document arrest and prevention of dental caries by silver diamine fluoride. This off-label use is now permissible and appropriate under U.S. law. A CDT code was approved for caries arresting medicaments for 2016 to facilitate documentation and billing. We present a systematic review, clinical indications, clinical protocol and consent procedure to guide application for caries arrest treatment.
